PubRank

Canadian journal of gastroenterology & hepatology (Can J Gastroenterol Hepatol)

Journal PubWeight™ 243.69‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 An update on the management of chronic hepatitis C: 2015 Consensus guidelines from the Canadian Association for the Study of the Liver. 2015 1.86
2 Burden of disease and cost of chronic hepatitis C infection in Canada. 2014 1.59
3 Examining the clinical use of hemochromatosis genetic testing. 2015 1.45
4 Prebiotics: A Novel Approach to Treat Hepatocellular Carcinoma. 2017 1.39
5 Autoimmune Hepatitis: Progress from Global Immunosuppression to Personalised Regulatory T Cell Therapy. 2016 1.39
6 Assessment of School Readiness in Chronic Cholestatic Liver Disease: A Pilot Study Examining Children with and without Liver Transplantation. 2017 1.39
7 Physicians' practices for diagnosing liver fibrosis in chronic liver diseases: a nationwide, Canadian survey. 2014 1.37
8 Patient preference and willingness to pay for transient elastography versus liver biopsy: A perspective from British Columbia. 2015 1.19
9 Defining quality indicators for best-practice management of inflammatory bowel disease in Canada. 2014 1.19
10 Evaluation of Antiviral Therapy Performed after Curative Therapy in Patients with HBV-Related Hepatocellular Carcinoma: An Updated Meta-Analysis. 2016 1.17
11 Patient-reported outcome measures in inflammatory bowel disease. 2014 1.07
12 Fecal occult blood testing as a diagnostic test in symptomatic patients is not useful: a retrospective chart review. 2014 1.06
13 Safety and efficacy of Hemospray® in upper gastrointestinal bleeding. 2014 1.05
14 Position of the Canadian Association of Gastroenterology on subsequent entry biologics is challenged by biosimilar industry representatives. 2014 1.05
15 Registered nurse-performed flexible sigmoidoscopy in Ontario: development and implementaton of the curriculum and program. 2014 1.04
16 Iron overload is rare in patients homozygous for the H63D mutation. 2014 1.04
17 Living with inflammatory bowel disease: A Crohn's and Colitis Canada survey. 2015 1.03
18 Colonoscopy quality assurance in Ontario: Systematic review and clinical practice guideline. 2014 1.01
19 Hepatitis C drugs: the end of the pegylated interferon era and the emergence of all-oral interferon-free antiviral regimens: a concise review. 2014 1.00
20 FibroScan® access in Canada: Time for reform, a call for universal access. 2015 0.98
21 Noninvasive diagnosis of liver fibrosis: The importance of being reimbursed. 2015 0.97
22 Comment on "Evaluation of Antiviral Therapy Performed after Curative Therapy in Patients with HBV-Related Hepatocellular Carcinoma: An Updated Meta-Analysis". 2016 0.97
23 Assessment of Liver Stiffness in Pediatric Fontan Patients Using Transient Elastography. 2016 0.96
24 Geographical variation and factors associated with colorectal cancer mortality in a universal health care system. 2014 0.95
25 H63D genotying for hemochromatosis: helper or hindrance? 2014 0.95
26 The feasibility and reliability of transient elastography using Fibroscan®: a practice audit of 2335 examinations. 2014 0.94
27 Yield of screening colonoscopy in renal transplant candidates. 2015 0.93
28 Biomarkers as potential treatment targets in inflammatory bowel disease: A systematic review. 2015 0.93
29 Characterization of inflammatory bowel disease in elderly hospitalized patients in a large central Canadian Health region. 2015 0.92
30 Safety of Digestive Endoscopy following Acute Coronary Syndrome: A Systematic Review. 2016 0.92
31 Anaplastic large cell lymphoma of the colon in a patient with colonic Crohn disease treated with infliximab and methotrexate. 2014 0.92
32 Novel diagnostic and therapeutic techniques for surveillance of dysplasia in patients with inflammatory bowel disease. 2014 0.92
33 Physician attitudes toward the use of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection. 2014 0.91
34 Physician global assessments or blood tests do not predict mucosal healing in ulcerative colitis. 2014 0.90
35 Atypical distribution of inflammation in newly diagnosed ulcerative colitis is not rare. 2014 0.90
36 Gaps in the hepatitis C continuum of care among sex workers in Vancouver, British Columbia: Implications for voluntary hepatitis C virus testing, treatment and care. 2015 0.90
37 Rates of minor adverse events and health resource utilization postcolonoscopy. 2014 0.89
38 Practice and documentation of performance of colonoscopy in a central Canadian health region. 2014 0.89
39 Endoscopic transmural necrosectomy for walled-off pancreatic necrosis: a systematic review and meta-analysis. 2013 0.87
40 Hepatitis C and the sex trade. 2015 0.87
41 Clinicians' guide to the use of fecal calprotectin to identify and monitor disease activity in inflammatory bowel disease. 2015 0.87
42 Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: The patient perspective. 2015 0.86
43 Fecal calprotectin use in inflammatory bowel disease and beyond: A mini-review. 2015 0.86
44 Colon capsule endoscopy: detection of colonic polyps compared with conventional colonoscopy and visualization of extracolonic pathologies. 2014 0.86
45 Partially covered self-expandable metal stents versus polyethylene stents for malignant biliary obstruction: A cost-effectiveness analysis. 2015 0.86
46 Validation of the National Aeronautics and Space Administration Task Load Index as a tool to evaluate the learning curve for endoscopy training. 2014 0.86
47 Transient elastography in Canada: Current state and future directions. 2015 0.85
48 Canadian Association of Gastroenterology position statement: fecal microbiota transplant therapy. 2014 0.85
49 Canadian Association of Gastroenterology policy on the application for, and implementation of, clinical practice guidelines. 2014 0.85
50 Comment on "Assessment of Liver Stiffness in Pediatric Fontan Patients Using Transient Elastography". 2016 0.85
Next 50